Table 2 Demographic and baseline clinical characteristics
Characteristic | Hydromorphone (N = 99) | Morphine (N = 101) |
|---|---|---|
Mean (SD) age, years | 60.7 (12.50) | 59.0 (11.36) |
Gender, % male | 46.5 | 51.5 |
Race, % Caucasian/Black/Asian/Other | 100/0/0/0 | 97/0/2/1 |
Mean (SD) height, cm | 166.7 (9.33) | 167.3 (10.47) |
Mean (SD) weight, kg | 66.3 (15.33) | 67.4 (13.33) |
Mean (SD) BMI, kg/m2 | 23.8 (5.14) | 24.2 (5.06) |
Cancer type, n (%) | ||
Breast | 23 (23.2) | 33 (32.7) |
Lung | 20 (20.2) | 19 (18.8) |
Genitourinary | 18 (18.2) | 12 (11.9) |
Gastrointestinal | 17 (17.2) | 15 (14.9) |
Oral cavity | 3 (3.0) | 3 (3.0) |
Lymphoma | 3 (3.0) | 0 |
Leukemia | 1 (1.0) | 2 (2.0) |
Bone | 1 (1.0) | 1 (1.0) |
Other | 13 (13.1) | 16 (15.8) |
Predominant pain type, n (%) | ||
Bone or soft tissue | 61 (61.6) | 72 (71.3) |
Mixed | 19 (19.2) | 15 (14.9) |
Visceral | 19 (19.2) | 14 (13.9) |
Mean (SD) MMSE score* | 28.5 (2.3) | 28.8 (2.0) |
Mean (SD) ECOG score | 1.6 (0.8) | 1.6 (0.9) |